Company Quick10K Filing
BioRestorative Therapies
10-K 2020-12-31 Filed 2021-04-30
10-Q 2020-09-30 Filed 2021-04-12
10-Q 2020-06-30 Filed 2021-04-12
10-Q 2020-03-31 Filed 2021-03-29
10-K 2019-12-31 Filed 2021-03-18
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-14
S-1 2019-04-26 Public Filing
10-Q 2019-03-31 Filed 2019-05-15
10-K 2018-12-31 Filed 2019-03-29
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-14
10-Q 2018-03-31 Filed 2018-05-15
10-K 2017-12-31 Filed 2018-04-02
10-Q 2017-09-30 Filed 2017-11-14
10-Q 2017-06-30 Filed 2017-08-14
10-Q 2017-03-31 Filed 2017-05-15
10-K 2016-12-31 Filed 2017-03-22
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-Q 2016-03-31 Filed 2016-05-13
10-K 2015-12-31 Filed 2016-03-30
10-Q 2015-09-30 Filed 2015-11-23
10-Q 2015-06-30 Filed 2015-08-14
10-Q 2015-03-31 Filed 2015-05-15
10-K 2014-12-31 Filed 2015-03-31
10-Q 2014-09-30 Filed 2014-11-13
10-Q 2014-06-30 Filed 2014-08-14
10-Q 2014-03-31 Filed 2014-05-14
10-K 2013-12-31 Filed 2014-04-11
10-Q 2013-09-30 Filed 2013-11-19
10-Q 2013-06-30 Filed 2013-08-19
10-Q 2013-03-31 Filed 2013-05-15
10-K 2012-12-31 Filed 2013-04-02
10-Q 2012-09-30 Filed 2012-11-05
10-Q 2012-06-30 Filed 2012-08-14
10-Q 2012-03-31 Filed 2012-05-14
10-K 2011-12-31 Filed 2012-04-16
10-Q 2011-09-30 Filed 2011-11-21
10-Q 2011-06-30 Filed 2011-08-17
8-K 2020-11-16
8-K 2020-10-30
8-K 2020-04-23
8-K 2020-03-30
8-K 2020-03-16
8-K 2020-02-28
8-K 2020-02-20
8-K 2020-02-20
8-K 2020-02-13
8-K 2020-02-11
8-K 2020-02-03
8-K 2020-01-27
8-K 2020-01-20
8-K 2020-01-10
8-K 2020-01-08
8-K 2019-12-31
8-K 2019-12-19
8-K 2019-12-12
8-K 2019-12-02
8-K 2019-11-20
8-K 2019-11-13
8-K 2019-11-01
8-K 2019-10-30
8-K 2019-10-16
8-K 2019-10-07
8-K 2019-09-30
8-K 2019-08-30
8-K 2019-08-21
8-K 2019-07-26
8-K 2019-07-11
8-K 2019-06-18
8-K 2019-06-06
8-K 2019-05-30
8-K 2019-05-22
8-K 2019-05-07
8-K 2019-04-30
8-K 2019-04-18
8-K 2019-02-19
8-K 2019-02-06
8-K 2019-01-22
8-K 2019-01-04
8-K 2018-12-21
8-K 2018-12-13
8-K 2018-11-20
8-K 2018-10-28
8-K 2018-10-15
8-K 2018-10-04
8-K 2018-09-20
8-K 2018-09-06
8-K 2018-08-31
8-K 2018-08-21
8-K 2018-08-06
8-K 2018-06-27
8-K 2018-05-31
8-K 2018-05-24
8-K 2018-01-16
8-K 2018-01-12

BioRestorative Therapies Financials

BRTX Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin

Comps ($'000 TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Banner Energy Services Corp. (BANM)
AVIENT CORP (AVNT)
11 Good Energy (ELVN)
COWEN INC. (COWNL)
1347 Capital Corp (TFSC)
CAI International, Inc. (CAI-PA)
Avianca Holdings S.A. (AVHOQ)
Gamco Investors (GBL) 505,641 0% 4.3 45% 179,495 146,777 307,065 0 80,872 102,868 443,648
BANK BRADESCO (BBDO)
BIO-RAD LABORATORIES, INC. (BIO-B)
Fortress Transportation & Infrastructure Investors LLC (FTAI-PC)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
1st Financial Services Corp (FFIS)
Intevac (IVAC) 106,629 33% -678.8 -3% 124,284 35,098 73,440 24,374 -4,054 -133 90,277
1st United Bancorp (FUBC)
CIT GROUP INC (CIT-PB)
2-Track Global (TTG)
ALABAMA POWER CO (APRCP)

Balance Sheet ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash15723131040499012011105937492146613167353516632921452941051184961,28498
Accounts Receivable519391656720163819372629293138
Inventory12141418181818172222
PP&E33195697969165504133177261874652537702663941599602556950463417370954286257214865141136106
Assets403221881,3421,3971,2681,7761,2501,2241,3831,2531,1861,5961,6921,8582,0712,1512,0172,0492,1961,6171,5801,4811,4241,4191,7591,2231,2061,2511,1921,5842,4321,458
Accounts Payable6584267394407007717731,0031,1561,2701,2038937741,1121,2661,7472,1102,5492,1942,0701,9942,2842,2842,4672,7182,4552,3862,2772,1121,8941,5681,5271,744
Long-Term Debt3,5943,5553,6320524275776238330830422302049948729813812062194843691,191524488201157
Liabilities3,7473,9074,4145,6006,4756,4106,6146,9867,8588,0688,2368,3358,0548,5809,2534,9515,9275,9255,5906,2016,0886,5806,2027,1398,1098,5958,91411,07410,1899,8339,23711,37513,887
Stockholders' Equity-3,344-3,686-4,326-4,258-5,078-5,142-4,838-5,736-6,634-6,685-6,983-7,149-6,458-6,888-7,395-2,881-3,776-3,908-3,541-4,005-4,471-5,000-4,722-5,715-6,690-6,837-7,690-9,868-8,938-8,641-7,653-8,942-12,429
Income Statement ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue0001050100001761608018514996199916567221638194026293138
Cost of Revenue100000042661057675516000000000
Gross Profit401000013494-261087445140916567221638
R&D12255190170400373415406494372291353407452616630866609656753806760491245407373357455442410
SG&A5122263994022702866706015315786687015456079637456371,6949251,0016267921,2261,7037458941,4101,9614401,3031,1841,073
Tax000
Net Income-1,013-743-1,494-1,646-1,477-1,919-1,566-1,251-1,303-1,631-1,670-1,333-1,100-1,484-1,760-1,420-1,624-3,119-2,487-2,258-1,834-2,057-2,786-2,747-2,052-1,860-2,508-3,514-2,925-3,883-4,157-5,057
Cash Flow ($'000)2011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating-1,116-394-1,257-451-1,083-772-702-434-764-807-834-634-675-810-584-1,054-1,718-1,018-1,206-1,062-1,219-766-509-1,360-1,158-1,353-1,980-1,417-1,711
Cash Investing0-1,00300000-111-2-167-167-60-209-48-90-61-31-7000-40-6
Cash Financing1,1723262,2695429791,2702044359757151,1505198967307991,2551,9941,2427261,0941,1967595081,8147151,4552,3592,234531